Navigation Links
LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results

CINCINNATI, Feb. 11 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus brand, today announced fourth quarter and full-year financial and operational results for the period ended December 31, 2007.

Fourth Quarter Financial & Operational Highlights (all comparisons are versus the fourth quarter of 2006)

-- Revenue increased 24% to $69.7 million from $56.0 million; adjusted

revenue increased 7% to $62.9 million from $58.8 million.

-- Procedure volume decreased 5% to 39,888 from 42,049.

-- Same-store revenue increased 13%; adjusted same-store revenue

decreased 4%.

-- Operating income was $5.9 million compared with $6.9 million; adjusted

operating loss was $0.3 million compared with adjusted operating income

of $9.3 million.

-- Net income and earnings per diluted share were $4.1 million and $0.22,

compared with $5.6 million and $0.27.

-- Repurchased 588,408 shares or approximately $10 million of LCA-Vision

common stock.

-- Opened two new LasikPlus vision centers in Coral Springs, Florida and

Chandler, Arizona.

Full-Year Financial & Operational Highlights (all comparisons are versus the full-year of 2006)

-- Revenue increased 22% to $292.6 million from $238.9 million; adjusted

revenue increased 11% to $284.6 million from $256.9 million.

-- Procedure volume increased 4% to 192,204 procedures from 185,268


-- Operating income increased 12% to $45.6 million from $40.8 million;

adjusted operating income was $38.4 million compared with

$57.0 million.

-- Net income and earnings per diluted share were $32.5 million and $1.64,

compared with $28.4 million and $1.34.

-- Repurchased 1,627,638 shares or approximately $44.5 million of

LCA-Vision common stock und128 -

Changes in working capital:

Patient accounts receivable (11,500) (3,903)

Other accounts receivable 1,080 (1,087)

Prepaid expenses and other 1,338 (2,383)

Prepaid income taxes (4,035) 520

Accounts payable 5,132 1,464

Deferred revenue, net of professional

fees (7,212) 16,202

Accrued liabilities and other 4,898 1,364

Net cash provided by operations 54,979 51,661

Cash flows from investing activities:

Purchases of property and equipment (28,864) (9,656)

Purchases of investment securities (330,826) (308,943)

Proceeds from sale of investment

securities 356,874 238,013

Other, net 278 119

Net cash used in investing activities (2,538) (80,467)

Cash flows from financing activities:

Principal payments of capital lease

obligations (5,782) (2,795)

Shares repurchased for treasury stock (44,940) (51,816)

Tax benefits related to stock-based

compensation 2,121 5,409

Exercise of stock options 3,499 5,528

Dividends paid to stockholders (13,984) (11,131)

Other (172) (19)

Net cash used in financing activities (59,258) (54,824)

Decrease in cash and cash equivalents (6,817) (83,630)

Cash and cash equivalents at beginning of year 24,431 108,061

Cash and cash equivalents at end of year $17,614 $24,431

LCA-Vision Inc.

Effect of the Change in Our Accounting for Deferred Revenues on Financial



(dollars in thousands)

To supplement its condensed consolidated financial statements presented in

accordance with accounting principles generally accepted in the United

States, LCA-Vision discusses revenues and operating income, as adjusted.

Management utilizes this information as a means of measuring performance

for the non-cash impact of the accounting for separately priced extended

warranties, as adjusted, and believes that including this additional

disclosure is meaningful to investors for the same reason.

Accordingly, this news release contains non-GAAP financial measures within

the meaning of Regulation G promulgated by the Securities and Exchange

Commission. A reconciliation of the differences between the non-GAAP

measures with the most directly comparable financial measures calculated

in accordance with GAAP follows:

Three Months Ended Twelve Months Ended

December 31, December 31,

2007 2006 2007 2006


Reported (GAAP) $69,702 $56,037 $292,635 $238,925


Warranty revenue deferred

into future - 8,907 20,054 38,539

Amortization of prior

deferred revenue (6,836) (6,167) (28,067) (20,537)

Adjusted revenue (Non-GAAP) $62,866 $58,777 $284,622 $256,927

Operating Income

Reported (GAAP) $5,852 $6,851 $45,565 $40,779


Impact of warranty revenue

deferral (6,836) 2,740 (8,013) 18,002

Professional fees deferred

into future - (891) (2,005) (3,854)

Amortization of prior

professional fees 684 617 2,807 2,054

Adjusted operating income

(Non-GAAP) $(300) $9,317 $38,354 $56,981

Effective June 15, 2007, LCA-Vision eliminated the use of separately

priced extended warranties. Therefore, no warranty-related revenue

deferrals have occurred or will occur for procedures performed after that


er the board authorized program.

-- Opened 13 new LasikPlus vision centers.

LCA-Vision is providing adjusted revenue and operating income to investors as a means of measuring performance that adjusts for the non-cash impact of the accounting for separately priced extended warranties. A reconciliation of revenue and operating income as reported in accordance with Generally Accepted Accounting Principles (GAAP) is provided on the last page of this news release. Management believes the adjusted information is more reflective of operating performance. Effective June 15, 2007, the company eliminated the use of separately priced extended warranties. No warranty-related revenue deferrals have occurred or will occur for procedures performed after that date.

LCA-Vision's Chief Executive Officer, Steve Straus, commented, "Despite the challenging economic environment and its impact on our industry, LCA-Vision grew procedure volume by 4% and adjusted revenue by 11% in 2007. We continue to invest in our core business by entering new markets and equipping our surgeons with the best available technology."

Mr. Straus continued, "Last October, we announced the national rollout of the IntraLase femtosecond technology in our LasikPlus vision centers across the country. As of December 31, 2007, IntraLase was installed and operational in 45 LasikPlus vision centers, and at the end of January, IntraLase was installed and operational in 53 LasikPlus vision centers. We expect to complete the installation of IntraLase in our LasikPlus vision centers early in the second quarter of this year. The IntraLase technology has been well received by consumers. On an adjusted basis, our average price per procedure increased 7% for the full-year of 2007 to $1,481 from $1,387 for the full-year of 2006, primarily as a result of the adoption of IntraLase, and the elimination of separately-priced warranties. In January, 2008, IntraLase utilization increased to 37% of total procedures, from 31% in December, 2007, and 11% in October, 2007."

Cash Position

Net cash provided by operating activities increased 6% in 2007 to $55.0 million from $51.7 million in 2006. Cash and short-term investments were $62.4 million at December 31, 2007.

Share Repurchase

In August 2007, LCA-Vision announced that its board of directors authorized a share repurchase plan under which the company was authorized to purchase $50 million of its common stock. During the fourth quarter, the company repurchased 588,408 shares of its common stock at an average price of $16.99 for a total cost of approximately $10 million. Approximately $40 million remains for repurchase under this plan.

LasikPlus Vision Centers

LCA-Vision opened 13 new LasikPlus vision centers in 2007, and recently announced the opening of its 73rd LasikPlus vision center in Savannah, Georgia. LasikPlus vision centers are now located in 57 markets and 32 states.


"We expect the U.S. economy, including its impact on consumer spending habits and our industry, to continue to be challenging throughout 2008, and we estimate that industry procedure volumes could decline by more than 10%," added Mr. Straus. "However, we remain committed to selectively invest in our national expansion by opening vision centers in new markets, and relocating and renovating existing vision centers. We have plans to open five to ten vision centers during the year, and relocate four to seven existing locations. We are leveraging consumer insights from extensive market research conducted over the past several months to optimize our marketing efforts, as well as to refine our strategies of convenience and affordability. We recently updated our LasikPlus website with dynamic functionality and other enhancements, and have shifted hours of operations at many of our vision centers to be more consumer-friendly. We continue to focus on delivering an exceptional experience and outcome at an affordable price to every patient who visits our LasikPlus vision centers."

"We have implemented a number of business improvements that we expect will positively impact our business later this year, as well as in the years to come. Specifically, we are implementing a sales effectiveness training program in our call center and in our vision centers to improve our key operating metrics, and we are investing in management effectiveness training throughout all levels of operations management. At the same time, we are prudently managing expenses. We recently reduced our workforce throughout the U.S. by approximately 16% so that our staffing levels are appropriate for the expected procedure volume. In addition, we are diligently managing our general and administrative costs. LCA-Vision is an established company -- built on a solid foundation. We are confident that we will be able to manage through this economic uncertainty, and that our business initiatives will allow us to continue to capture market share, and position the company for long-term value."

Conference Call and Webcast

As previously announced, a conference call and webcast will be held today, Monday, February 11, 2008 at 10:00 a.m. (ET). To access the conference call, dial 866-322-1352 (within the United States and Canada), or 706-758-1564 (international callers). The webcast and presentation will be available at the investor relations section of LCA-Vision's website. A replay of the call and webcast will begin approximately two hours after the live call has ended. To access the replay, dial 800-642-1687 (within the United States and Canada), or 706-645-9291 (international callers) and enter the conference ID number: 297 23 746.

Forward-Looking Statements

This news release contains forward-looking statements based on current expectations, forecasts and assumptions of LCA-Vision that are subject to risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Actual results could differ materially from those stated or implied in such forward-looking statements due to risks and uncertainties associated with our business, including, without limitation, those concerning economic, political and sociological conditions; the acceptance rate of new technology, and our ability to successfully implement new technology on a national basis; market acceptance of our services; the successful execution of marketing strategies to cost effectively drive patients to our vision centers, which recent results would indicate are no longer as effective as they have been in prior periods; competition in the laser vision correction industry; an inability to attract new patients; the possibility of long-term side effects and adverse publicity regarding laser vision correction; legal or regulatory action against us or others in the laser vision correction industry; our ability to successfully open new vision centers, including our ability to get new vision centers to reach profitability targets within a specified time period; the relatively high fixed cost structure of our business; the continued availability of non- recourse third-party financing for our patients on terms similar to what the company has paid historically; and the future value of revenues financed by us and our ability to collect on such financings which will depend on a number of factors, including the consumer credit environment and our ability to manage credit risk related to consumer debt, bankruptcies and other credit trends. For a further discussion of the factors that may cause actual results to differ materially from current expectations, please review our filings with the Securities and Exchange Commission, including but not limited to our Forms 10-K/A and 10-Q. Except to the extent required under the federal securities laws and the rules and regulations promulgated by the Securities and Exchange Commission, we assume no obligation to update the information included in this news release, whether as a result of new information, future events or circumstances, or otherwise.

About LCA-Vision Inc./LasikPlus

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus brand, operates 73 LasikPlus fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at and

Earning Trust Every Moment. Transforming Lives Every Day.

For Additional Information

Patricia Forsythe

V.P. Investor Relations


LCA-Vision Inc.

Consolidated Statements of Income

(dollars in thousands, except per share amounts)

Three Months Ended Twelve Months Ended

December 31, December 31,

Unaudited Unaudited

2007 2006 2007 2006

Revenue -- Laser refractive

surgery $69,702 $56,037 $292,635 $238,925

Operating costs and expenses

Medical professional and

license fees 11,574 9,564 49,312 42,954

Direct costs of services 25,024 19,598 97,423 77,612

General and administrative

expenses 7,432 5,458 22,657 21,156

Marketing and advertising 16,369 12,307 66,469 47,971

Depreciation 3,451 2,259 11,209 8,453

Operating income 5,852 6,851 45,565 40,779

Equity in earnings from

unconsolidated businesses 217 242 814 746

Net investment income 1,075 1,802 5,953 6,182

Other (598) (7) (607) (27)

Income before taxes on income 6,546 8,888 51,725 47,680

Income tax expense 2,400 3,315 19,221 19,310

Net income $4,146 $5,573 $32,504 $28,370

Income per common share

Basic $0.22 $0.27 $1.66 $1.37

Diluted $0.22 $0.27 $1.64 $1.34

Dividends declared per share $0.18 $0.18 $0.72 $0.54

Weighted average shares outstanding

Basic 18,790 20,335 19,572 20,694

Diluted 18,862 20,629 19,858 21,235

LCA-Vision Inc.

Consolidated Balance Sheets

(dollars in thousands, except per share amounts)

At December 31,


2007 2006


Current assets

Cash and cash equivalents $17,614 $24,431

Short-term investments 44,784 70,801

Patient receivable, net of allowance

for doubtful accounts of $3,628 and

$2,310 12,071 11,269

Other accounts receivable 5,941 7,021

Prepaid professional fees 1,872 2,223

Prepaid income taxes 6,391 2,356

Deferred tax assets 4,750 11,155

Prepaid expenses and other 5,076 6,414

Total current assets 98,499 135,670

Property and equipment 106,788 77,323

Accumulated depreciation and amortization (52,872) (46,399)

Property and equipment, net 53,916 30,924

Accounts receivable, net of allowance for

doubtful accounts of $1,489 and $532 5,197 2,174

Deferred compensation plan assets 5,540 4,090

Investment in unconsolidated businesses 590 904

Deferred tax assets 12,261 12,141

Other assets 3,644 4,256

Total assets $179,647 $190,159

Liabilities and stockholders' investment

Current liabilities

Accounts payable $10,396 $5,264

Accrued liabilities and other 13,861 9,800

Deferred revenue 18,719 22,234

Capital lease obligations maturing

in one year 3,941 3,360

Total current liabilities 46,917 40,658

Capital lease obligations 2,012 2,431

Deferred compensation liability 5,516 4,136

Insurance reserve 8,493 6,163

Deferred revenue 23,110 27,608

Minority equity interest - 47

Stockholders' investment

Common stock ($.001 par value;

25,114,244 and 24,814,542 shares and

18,482,658 and 19,821,348 shares issued

and outstanding, respectively) 25 25

Contributed capital 172,965 162,245

Common stock in treasury, at cost

(6,631,586 shares and 4,993,194 shares) (114,427) (69,487)

Retained earnings 34,597 16,320

Accumulated other comprehensive income 439 13

Total stockholders' investment 93,599 109,116

Total liabilities and stockholders' investment $179,647 $190,159

LCA-Vision Inc.

Consolidated Statements of Cash Flows

(dollars in thousands)

Years Ended December 31,


2007 2006

Cash flow from operating activities:

Net income $32,504 $28,370

Adjustments to reconcile net income to net

cash provided by operating activities:

Depreciation 11,209 8,453

Provision for loss on doubtful accounts 7,675 1,855

Deferred income taxes 6,222 (6,436)

Stock-based compensation 5,024 5,665

Insurance reserve 2,330 2,323

Equity in earnings from unconsolidated

affiliates (814) (746)

Distributions from unconsolidated

affiliates 1,

SOURCE LCA-Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Announces Upcoming Investment Community Events
2. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
3. Neurobiological Technologies Reports Second Quarter Financial Results
4. Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results
5. Bioniche Reports Fiscal 2008 Second Quarter
6. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
7. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
8. Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Womens Health Watch
9. Pathology Reports Good for Breast Cancer Studies
10. American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
11. J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)...  As the latest Obamacare repeal effort moves is ... (R-LA) and Lindsey Graham (R-SC) medical device ... industry is in an odd place.  The industry wants ... tax on medical device sales passed along with the ... increased visits and hospital customers with the funding to ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
(Date:9/18/2017)... Pa. and KALAMAZOO, Mich. , Sept. 18, ... , and OptiMed Specialty Pharmacy of ... to offer a strategic hub service that expedites and ... sought-after personal spirometer, Spiro PD 2.0, and wellness management ... spirometer is a medical device used to measure lung ...
Breaking Medicine Technology: